Recruiting A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study) NCT07065240 Conditions Anxiety Disorders, Behavior, Behavioral Symptoms, +7 more Locations Seaport Investigator Site — Chino, California, United States Seaport Investigator Site — Garden Grove, California, United States Seaport Investigator Site — Glendale, California, United States Seaport Investigator Site — Redlands, California, United States View all 61 locations View more locations Show fewer locations Loading locations... View Trial Details
Enrolling by Invitation An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study) NCT07161700 Conditions Anxiety Disorders, Behavior, Behavioral Symptoms, +7 more Locations Seaport Investigator Site — Chino, California, United States Seaport Investigator Site — Garden Grove, California, United States Seaport Investigator Site — Glendale, California, United States Seaport Investigator Site — West Palm Beach, Florida, United States View all 32 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed A Study of JNJ-61393215 in the Treatment of Depression NCT04080752 Conditions Major Depressive Disorder With Anxious Distress Locations Collaborative NeuroScience Network — Garden Grove, California, United States Atlanta Institute — Alpharetta, Georgia, United States Atlanta Center for Medical Research — Atlanta, Georgia, United States The Medical Research Network, LLC — New York, United States View all 35 locations View more locations Show fewer locations Loading locations... View Trial Details
